Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Monitoring expenses reveals patterns like recurring charges or impulsive buys. Look for spikes, then adjust categories to optimize your plan.
17,195 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A BrightEdge analysis shows google’s overviews more likely to surface negative brand signals than ChatGPT, with broad...
A fast-moving shift in AI could turn cyber threats into a global financial crisis if firms don’t act. This article br...
Crypto development is a high-stakes battleground for malware. This article explains how a perplexity built tool that ...
A June breach hit Humanity Protocol’s H token on Ethereum and BNB Smart Chain, revealing key-management vulnerabiliti...
A bold new AI model from Z.AI promises high performance without Nvidia chips. This article breaks down what GLM-5.2 m...
A provocative jailbreak method exposed a flaw in AI chatbots, prompting researchers to rethink safety guardrails. Thi...
U.S. Treasury freezes about $131 million in iran-linked crypto with $131m assets tied to Iran, as sanctions and on-ch...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
Egg prices have fallen sharply as the worst of the avian flu outbreak eases, but traders warn that fresh outbreaks co...
In a bold move, Solv Protocol plans to dump its LayerZero-backed tokenized Bitcoin tech and migrate to Chainlink. Thi...
Strategy stock essentially leveraged means the company borrows to buy Bitcoin, making its fate closely tied to crypto...